Known, emerging, novel
Reports do not mix established disease genes with exploratory candidates. The distinction is part of the trust model.
Atlas separates established disease biology from emerging candidate genes and novel, testable hypotheses. Each report shows the evidence path, uncertainty, and validation routes behind the ranking.
Current Atlas report
Coming soonPublication is being prepared around established Alzheimer's genetics and mechanism themes, including amyloid processing, APOE-linked lipid biology, and microglial immune biology.
5
known anchors
Review
candidate ranking
Pending
public release
Established disease genetics and lipid biology context
Established amyloid processing biology
Established amyloid processing biology
Established amyloid processing biology
Established microglial immune biology context
Publication standard
The published report will separate established disease biology from exploratory candidate hypotheses and will mark indirect evidence, uncertainty, and validation routes before any candidate is presented as research-priority material.
Reports do not mix established disease genes with exploratory candidates. The distinction is part of the trust model.
Candidate genes are connected back to disease context through structured paths, not free-form invention.
Novel hypotheses include why they may be wrong and what validation would make them more credible.